Abstract:Migraine, a primary headache disorder whose mechanism remains incompletely understood, appears to involve the activation of the trigeminovascular system (TS) during attacks. Research suggests that inflammatory processes mediated by the immune system may play a role in migraine pathophysiology. Neuroinflammation is often associated with migraine attacks, with cytokines serving as crucial mediators in the process. Elevated levels of pro-inflammatory cytokines, such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), have been observed in the blood and cerebrospinal fluid of individuals experiencing migraine attacks. These cytokines have the capacity to sensitize pain pathways in the brain, thereby increasing sensitivity to pain stimuli. This phenomenon, known as central sensitization, is believed to contribute to the intensity and persistence of migraine pain. Kynurenines, endogenous mediators of glutamatergic mechanisms, can significantly influence the pathophysiology of primary headache disorders. The kynurenine system is collectively known as the kynurenine pathway (KP), which can act on multiple receptors, such as glutamate receptors, aryl hydrocarbon receptors (AhRs), G protein-coupled receptors 35 (GPR35), and α-7 nicotinic acetylcholine (α7 nACh) receptors. These receptors are also found on various cells of the immune system, so the role of the KP in the pathomechanism of primary headaches may also be mediated through them. In this review, our goal is to show a possible link between the receptors of the KP and immune system in the context of inflammation and migraine. Migraine research in recent years has focused on neuropeptides, such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as potential pathogenic factors and possible therapeutic approaches. These peptides share many similarities in their characteristics and roles. For instance, they exhibit potent vasodilation, occur in both the peripheral and central nervous systems, and play a role in transmitting nociception and neurogenic inflammation. The investigation of potential connections between the aforementioned neuropeptides and the kynurenine pathway could play a significant role in uncovering the pathomechanism of migraine and identifying new drug candidates.

[The Role of the Tryptophan-Kynurenine Pathway in Neuropathic Pain].

Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects

Understanding pain in acute pancreatitis: A focus on kynurenine pathway dynamics

The role of the kynurenine pathway in cardiovascular disease

Understanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions

Neuroimmune-glial cells interactions elevate the kynurenine metabolic pathway to sustain neuropathic pain

Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities

Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders

Tryptophan Metabolism in Health and Disease

Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations

Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases

The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies

Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases

The Tryptophan and Kynurenine Pathway Involved in the Development of Immune-Related Diseases

The role of kynurenines in migraine-related neuroimmune pathways

The Kynurenine Pathway in Stem Cell Biology.

The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia

The kynurenine pathway: a finger in every pie

The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.

Meningeal Dendritic Cells Drive Neuropathic Pain Through Elevation of the Kynurenine Metabolic Pathway in Mice.

Meningeal dendritic cells-astrocytes interactions elevate the kynurenine metabolic pathway to sustain neuropathic pain